Saturday’s Midday Movers: Vipshop (VIPS), Tesla (TSLA), Tata Motors (TTM), Intercept Pharma (ICPT), uniQure NV (QURE)

By Carrie Williams

So far Saturday, October 26, NASDAQ is up 3.28% and the S&P is up 1.86%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Vipshop (VIPSResearch Report), Tesla (TSLAResearch Report), Tata Motors (TTMResearch Report), Intercept Pharma (ICPTResearch Report) and uniQure NV (QUREResearch Report).

Vipshop is up 12.78% in midday trading to $11.47. Shares opened today at $10.17. The company has a 52-week low of $4.31 and a 52-week high of $11.94. On the Street’s front, the average 12-month analyst price target for the stock is $9.71, marking a -4.52% potential downside from current levels. In a report issued on August 19, Merrill Lynch analyst Eddie Leung reiterated a Hold rating on VIPS, with a price target of , which represents a slight downside potential from current levels. Separately, on August 16, New Street Research’s Jin Yoon upgraded the stock to Buy and has a price target of $9.50.

Tesla is up 10.21% in midday trading to $328.13. Shares opened today at $297.72. The company has a 52-week low of $176.99 and a 52-week high of $379.49. On the Street’s front, the average 12-month analyst price target for the stock is $275.82, marking a -7.36% potential downside from current levels. In a report released yesterday, CLSA analyst Brian Johnson CFA maintained a Sell rating on TSLA. Separately, on the same day, Argus’ Bill Selesky maintained a Buy rating on the stock and has a price target of $396.00. Over the last 3 months, the insider sentiment on Tesla has been positive based on 52 corporate insider transactions. This sentiment is slightly higher than the average sector sentiment of insiders.

Tata Motors is up 8.26% in midday trading to $10.49. Shares opened today at $9.69. The company has a 52-week low of $7.38 and a 52-week high of $17.14.

See today’s analyst top recommended stocks >>

Intercept Pharma is up 7.08% in midday trading to $73.49. Shares opened today at $68.63. The company has a 52-week low of $56.76 and a 52-week high of $131.87. On the Street’s front, the average 12-month analyst price target for the stock is $148.27, marking a 116.04% potential upside from current levels. In a report issued on October 18, Jefferies Co. analyst Michael Yee maintained a Buy rating on ICPT, with a price target of $125.00, which represents a potential upside of 82% from where the stock is currently trading. Separately, on August 8, Stifel Nicolaus’ Derek Archila reiterated a Hold rating on the stock and has a price target of $86.00. In the last 30 days, insiders have sold $232.2K worth of ICPT shares. Over the last 3 months, the insider sentiment on Intercept Pharma has been positive based on 100 corporate insider transactions. This sentiment is slightly higher than the average sector sentiment of insiders.

uniQure NV is up 6.95% in midday trading to $49.43. Shares opened today at $46.22. The company has a 52-week low of $21.98 and a 52-week high of $82.49. On the Street’s front, the average 12-month analyst price target for the stock is $91.00, marking a 96.88% potential upside from current levels. In a report issued on October 14, H.C. Wainwright analyst Debjit Chattopadhyay maintained a Buy rating on QURE, with a price target of $73.00, which represents a potential upside of 58% from where the stock is currently trading. Separately, on July 29, Guggenheim’s Whitney Ijem downgraded the stock to Hold . Over the last 3 months, the insider sentiment on uniQure NV has been negative based on 44 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.

See today’s analyst top recommended stocks >>

Trending Stocks Based on Insider Activity >>